Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> ‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
France Rolls Back Hydroxychloroquine Recommendations For COVID-19; The United Kingdom Issues Emergency Use Approval For Remdesivir 27/05/2020 Gauri Saxena France rolled back recommendations on the use of hydroxychloroquine, a malaria drug, for severe COVID-19 patients, just two days after the World Health Organization suspended its large multinational hydroxychloroquine trial. Meanwhile, the United Kingdom has authorized the use of remdesivir for severe cases of COVID-19. The drug showed modest potential to shorten the length of […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> ‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> ‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> ‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> ‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> ‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> ‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts